EBITDA: Income before interest, taxes, depreciation and amortization.
NovaBay Pharmaceuticals, Inc. (SDEV) had EBITDA of $-1.91M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.60M |
|
-- |
|
-- |
|
$1.48M |
|
$-1.48M |
|
$-24.59M |
|
$-26.59M |
|
$-26.59M |
|
$-26.59M |
|
$-26.59M |
|
$-26.60M |
|
$-26.59M |
|
$-2.00M |
|
|
EBITDA |
$-1.91M |
5.82M |
|
5.82M |
|
$-8.25 |
|
$-8.15 |
|
| Balance Sheet Financials | |
$8.68M |
|
-- |
|
$0.36M |
|
$9.04M |
|
$1.14M |
|
-- |
|
$30.72M |
|
$31.86M |
|
$-23.18M |
|
$-22.83M |
|
$-22.83M |
|
25.22M |
|
| Cash Flow Statement Financials | |
$-8.43M |
|
-- |
|
$4.62M |
|
$0.91M |
|
$8.22M |
|
$7.32M |
|
$0.03M |
|
$-4.82M |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.60 |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
114.72% |
|
116.51% |
|
-294.36% |
|
116.51% |
|
$-0.91 |
|
$-1.45 |
|
$-1.45 |
|